On Invalid Date, Hookipa Pharma (NASDAQ: HOOK) reported Q4 2023 earnings per share (EPS) of -$0.22, up 37.5% year over year. Total Hookipa Pharma earnings for the quarter were -$24.82 million. In the same quarter last year, Hookipa Pharma's earnings per share (EPS) was -$0.16.
As of Q2 2024, Hookipa Pharma's earnings has grown year over year. Hookipa Pharma's earnings in the past year totalled -$81.58 million.
What is HOOK's earnings date?
Hookipa Pharma's earnings date is Invalid Date. Add HOOK to your watchlist to be reminded of HOOK's next earnings announcement.
What was HOOK's revenue last quarter?
On Invalid Date, Hookipa Pharma (NASDAQ: HOOK) reported Q4 2023 revenue of $7.41 million up 5.38% year over year. In the same quarter last year, Hookipa Pharma's revenue was $7.83 million.
What was HOOK's revenue growth in the past year?
As of Q2 2024, Hookipa Pharma's revenue has grown 41.27% year over year. This is 104.47 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Hookipa Pharma's revenue in the past year totalled $20.13 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.